The phrase "as a potential inducer" is correct and usable in written English.
It can be used in contexts where you are discussing something that may cause or trigger a particular effect or response.
Example: "The chemical compound was studied as a potential inducer of cell growth in the laboratory."
Alternatives: "as a possible catalyst" or "as a likely trigger".
sinica (recently used for the cardiovascular diseases treatment) as a potential inducer of autophagy in MCF-7 cell line.
In this study, we report α-solanine as a potential inducer of autophagy, which may act synergistically or in parallel with apoptosis to exert its cytotoxic effect.
Streptozotocin (STZ) is frequently used to induce diabetes in experimental animals through its toxic effects on pancreatic β-cells [ 8, 9] and as a potential inducer of oxidative stress.
Enhanced β-cell proliferation occurs naturally during pregnancy [ 5, 7] as well as obesity induced states of insulin resistance [ 8, 9].The recent discovery of betatrophin as a potential inducer of β-cell proliferation in mice in response to insulin resistance has revived the hope for achieving this goal [ 10, 11].
Our findings indicate a role for aTf as a potential inducer of OLs in neonatal rat brain in acute demyelination caused by H/I and a contribution to the differentiation/maturation of OLs and survival/migration of SVZ progenitors after demyelination in vivo.
Our results showed that dexamethasone as a potential inducer of CYP3A1 produced significant increase of its expression level in the liver tissues by over 4.4-fold (P < 0.01) after 3 days whereas long-term administration of this substance caused death of rats after 4 days as a result of hepatotoxicity effect.
In this study we provide evidence that dichlorophenyl form of thiadiazolidine (designated as P3-25) is a potential inducer of cell death by arresting cell cycle at G1 phase and decreases the amounts of cyclin D1 and cyclin E without interfering p16 and p27.
As IL-8 is a potential inducer of decreased CXCR1/2 expression, increased levels of circulating IL-8 in other clinical conditions may also result in a similar decline of CXCR1/2 expression.
Thus, in human RA as well as in other animal models of RA, the activation of JNK may be caused by another disease-relevant signalling pathway such as IL-1, which is a potential inducer of JNK phosphorylation in RA synovial cells.
This telomeric DNA damage response has also been shown to be a potential inducer of senescence or cell death [ 5- 7], as well as of in vivo aging in both model systems and human pathology [ 3].
Thus, we propose that chronically increased serum levels of TGF-β1 observed in many systemic diseases might be a potential inducer for associated loss of bone density, as seen in hepatic or renal osteodystrophy.
